Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND I: Asacol 4.8 g/day vs 2.4 g/day in Ulcerative Colitis
NCT00577473Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Feb 2001
- Primary completion
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Warner Chilcott. Started Feb 2001; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00577473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577473.